Nurix Therapeutics, Inc. (NRIX) Discusses Clinical and Preclinical Updates on BTK, STAT6, and IRAK4 Degrader Programs - Slideshow (NASDAQ:NRIX) 2025-10-23
Nurix TherapeuticsNurix Therapeutics(US:NRIX) Seeking Alpha·2025-10-23 17:05

Group 1 - The article does not provide any specific content or key points related to a company or industry [1]